Manulife (Manufacturers Life Insurance)
GYRE icon

Manulife (Manufacturers Life Insurance)’s Gyre Therapeutics GYRE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,736
Closed -$103K – 3244
2021
Q1 		$103K Buy
2,736
+635
+30% +$29K ﹤0.01% 3043
2020
Q4 		$99K Buy
+2,101
New +$91K ﹤0.01% 2955
2018
Q3 		– Sell
-5
Closed – – 3328
2018
Q2 		$0 Buy
+5
New +$877 ﹤0.01% 4322
2017
Q2 		– Sell
-1
Closed – – 4397
2017
Q1 		$0 Sell
1
-1
-50% -$58 ﹤0.01% 4266
2016
Q4 		$0 Hold
2
– – ﹤0.01% 4389
2016
Q3 		$0 Hold
2
– – ﹤0.01% 4309
2016
Q2 		$0 Hold
2
– – ﹤0.01% 4282
2016
Q1 		$0 Hold
2
– – ﹤0.01% 4128
2015
Q4 		$1 Hold
2
– – ﹤0.01% 3885
2015
Q3 		$1 Buy
2
+1
+100% +$1.52K ﹤0.01% 3920
2015
Q2 		$2 Hold
1
– – ﹤0.01% 3824
2015
Q1 		$2 Hold
1
– – ﹤0.01% 3804
2014
Q4 		$2 Hold
1
– – ﹤0.01% 3742
2014
Q3 		$2 Hold
1
– – ﹤0.01% 3768
2014
Q2 		$3K Sell
1
-27
-96% -$88.1K ﹤0.01% 3628
2014
Q1 		$105 Sell
28
-1
-3% -$3.7K ﹤0.01% 3051
2013
Q4 		$96 Buy
29
+10
+53% +$39.4K ﹤0.01% 3081
2013
Q3 		$78 Buy
19
+10
+111% +$40.2K ﹤0.01% 3084
2013
Q2 		$29K Buy
+9
New +$34.2K ﹤0.01% 3112

Other funds holding GYRE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GYRE Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Gyre Therapeutics (GYRE) in Q2 2021, closing a stake of 2,736 shares — an estimated $103K sold.

Manulife (Manufacturers Life Insurance) first reported a position in GYRE in Q2 2013 and held it in 19 quarters. The position peaked at $103K in Q1 2021. 69 funds tracked by Wall St. Rank hold GYRE as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Gyre Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,736 Gyre Therapeutics shares in Q2 2021, an estimated $103K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Gyre Therapeutics in Q2 2013 and held it in 19 quarters.
  • Manulife (Manufacturers Life Insurance)'s Gyre Therapeutics position peaked at $103K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.